Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
RELMADA THERAPEUTICS, INC. has filed 598 SEC EDGAR filings since 13 Nov 2012

SEC filing history

Showing 451-475 of 598 matching filings.

Per page
25
Current page
19
D File 021-296142

D filing

Filing date
06 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
04 Oct 2017
Reporting date
28 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-55347

ANNUAL REPORT

Filing date
28 Sep 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
15 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
08 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
18 May 2017
Reporting date
16 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
15 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
27 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
17 Feb 2017
Reporting date
13 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
10 Feb 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
01 Feb 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-55347

DEFINITIVE PROXY STATEMENT

Filing date
30 Dec 2016
Reporting date
27 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88207

INFORMATION TO BE INCLUDED IN STATEMENTS FILED

Filing date
23 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
10 Nov 2016
Reporting date
30 Sep 2016
Next action
Verify source filing
SC 13G/A File 005-88207

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
01 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
12 Sep 2016
Reporting date
06 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-55347

ANNUAL REPORT

Filing date
09 Sep 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
SC 13G File 005-88207

SCHEDULE 13G

Filing date
24 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
17 Jun 2016
Reporting date
16 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88207

SCHEDULE 13D/A

Filing date
02 Jun 2016
Reporting date
Not listed
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
13 May 2016
Reporting date
11 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
09 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
10-Q File 000-55347

QUARTERLY REPORT

Filing date
05 Feb 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
8-K File 000-55347

CURRENT REPORT

Filing date
13 Jan 2016
Reporting date
13 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jan 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .